Charles River (CRL) Forges Collaboration With Wheeler Bio

Charles River Laboratories International, Inc. (CRL) recently announced a strategic partnership with Wheeler Bio, an antibody CDMO (contract development and manufacturing organization) focused on the pre-clinical and early clinical supply of recombinant proteins, providing clients with access to Wheeler’s Portable CMC (Chemistry, Manufacturing and Controls) platform. The new alliance provides early-stage biotechnology companies with a unique solution to rapidly transition from pre-clinical activities to fir ...